ArticleFrontiers in immunology2025

VHH-based CAR-T cells targeting Claudin 18.2 show high efficacy in pancreatic cancer models.

Ying Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.